Nurix Therapeutics (NRIX) earnings, Oct 12, 2026: EPS +559%, stock −0.9%
In brief
Nurix Therapeutics reported on Oct 12, 2026. Earnings per share changed +559% year over year, 887.1% above the estimate; revenue +8,426%. The stock opened with a −0.4% gap and closed the day −0.9% (Oct 12, 2026). The stock is now 47.4% below its 52-week high, +19.1% over 12 months. Next report: Feb 17, 2027.
EPS vs estimate+887.1%
EPS, YoY+559%
Revenue, YoY+8,426%
Gap · day−0.4% · −0.9%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 9, 2026 | +2.4% | +1.6% |
| Oct 12, 2026 | −0.4% | −0.9% |
Next-quarter estimates, ratings and the NRIX chart are in the terminal.
Open the terminalFAQ
When is Nurix Therapeutics's next earnings report?
Feb 17, 2027. The date comes from daily data and is corrected if the company moves it.
How did Nurix Therapeutics stock react to the report?
Opening gap −0.4%, day's result −0.9%.
Did Nurix Therapeutics's earnings grow?
Earnings per share rose 559% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.